ERBB2 and breast cancer: When safe and accessible, a biopsy of metastatic breast cancer lesions is recommended to confirm the diagnosis, determine the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status, and potentially guide treatment.